The company's first product is an ultralight "echoscope" connected to a Software "APPs" Portfolio, each dedicated to a specific clinical specialty, which can be associated with pay per use or subscription business models. E-Scopics' focus is on NASH, offering an assessment of NASH using ultrasound-based tissue parameters to measure fat content in the Liver, Inflammation, and fibrosis. The company leverages proprietary technologies in Beamforming, Elastography, and Signal processing, and aims to expand its research towards AI and e-health specific areas.